Impact of aging on myocardial metabolic response to dobutamine

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 285, Issue 5 54-5, 2003, Pages

  Soto, Pablo F ^a   Herrero, Pilar ^b   Kates, Andrew M ^a   Dence, Carmen S ^b   Ehsani, Ali A ^a   Dávila Román, Victor ^a   Schechtman, Kenneth B ^a   Gropler, Robert J ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Catecholamine; Fatty acids; Glucose; Heart; Oxidation

Indexed keywords

DOBUTAMINE; FATTY ACID; GLUCOSE; INSULIN; LACTIC ACID; OXYGEN;

ADULT; AGED; AGING; ARTICLE; CONTROLLED STUDY; DRUG INFUSION; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FEMALE; GLUCOSE BLOOD LEVEL; HEART MUSCLE BLOOD FLOW; HEART MUSCLE METABOLISM; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; LACTATE BLOOD LEVEL; MALE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0142200922     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00086.2003     Document Type: Article

References (36)

1. American Heart Association. Heart Disease and Stroke Statistics - 2003 Update. Dallas, TX: American Heart Association, 2002.
2. American Heart Association. Leading Causes of Death - 1999. Dallas, TX: American Heart Association, 2002.
3. Amrani M, Goodwin AT, Gray CC, and Yacoub MH. Ageing is associated with reduced basal and stimulated release of nitric oxide by the coronary endothelium. Acta Physiol Scand 157: 79-84, 1996.
4. Bergmann SR, Herrero P, Markham J, Weinheimer CJ, and Walsh MN. Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol 14: 639-652, 1989.
5. Bergmann SR, Weinheimer CJ, Markham J, and Herrero P. Quantitation of myocardial fatty acid metabolism using PET. J Nucl Med 37: 1723-1730, 1996.
6. Braunwald E, Zipes DP, and Libby P. Heart Disease: A Textbook of Cardiovascular Medicine (6th ed). Philadelphia, PA: Saunders, 2001, p. 139,
7. Brown M, Marshall DR, Sobel BE, and Bergmann SR. Delineation of myocardial oxygen utilization with carbon-11-labeled acetate. Circulation 76: 687-696, 1987.
8. Brown MA, Myears DW, and Bergmann SR. Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization. J Nucl Med 30: 187-193, 1989.
9. Chauhan A, More RS, Mullins PA, Taylor G, Petch C, and Schofield PM. Aging-associated endothelial dysfunction in humans is reversed by L-arginine. J Am Coll Cardiol 28: 1796-1804, 1996.
10. Clark MG and Patten GS. Adrenergic regulation of glucose metabolism in rat heart. A calcium-dependent mechanism mediated by both alpha- and beta-adrenergic receptors. J Biol Chem 259:15204-15211, 1984.
11. Depre C, Vanoverschelde JL, and Taegtmeyer H. Glucose for the heart. Circulation 99: 578-588, 1999.
12. DiCarlo SE, Blair RW, Bishop VS, and Stone HL. Daily exercise enhances coronary resistance vessel sensitivity to pharmacological activation. J Appl Physiol 66: 421-428, 1989.
13. Doenst T and Taegtmeyer H. α-Adrenergic stimulation mediates glucose uptake through phosphatidylinositol 3-kinase in rat heart. Circ Res 84: 467-474, 1999.
14. Egashira K, Inou T, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Kuga T, Urabe Y, and Takeshita A. Effects of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans. Circulation 88: 77-81, 1993.
15. Gerber BL, Bernard X, Melin JA, Delestinne T, Vanbutsele R, Goenen M, and Vanoverschelde JL. Exaggerated chronotropic and energetic response to dobutamine after orthotopic cardiac transplantation. J Heart Lung Transplant 20: 824-832, 2001.
16. Gertz EW, Wisneski JA, Stanley WC, and Neese RA. Myocardial substrate utilization during exercise in humans. Dual carbon-labeled carbohydrate isotope experiments. J Clin Invest 82:2017-2025, 1988.
17. Goodwin GW, Ahmad F, Doenst T, and Taegtmeyer H. Energy provision from glycogen, glucose, and fatty acids on adrenergic stimulation of isolated working rat hearts. Am J Physiol Heart Circ Physiol 274: H1239-H1247, 1998.
18. Green CJ, Frazer RS, Underhill S, Maycock P, Fairhurst JA, and Campbell IT. Metabolic effects of dobutamine in normal man. Clin Sci (Lond) 82: 77-83, 1992.
19. Hall JL, Lopaschuk GD, Barr A, Bringas J, Pizzurro RD, and Stanley WC. Increased cardiac fatty acid uptake with dobutamine infusion in swine is accompanied by a decrease in malonyl CoA levels. Cardiovasc Res 32: 879-885, 1996.
20. Hall JL, Stanley WC, Lopaschuk GD, Wisneski JA, Pizzurro RD, Hamilton CD, and McCormack JG. Impaired pyruvate oxidation but normal glucose uptake in diabetic pig heart during dobutamine-induced work. Am J Physiol Heart Circ Physiol 271: H2320-H2329, 1996.
21. Herrero P, Weinheimer CJ, Dence C, Oellerich WF, and Gropler RJ. Quantification of myocardial glucose utilization by PET and 1-carbon-11-glucose. J Nucl Cardiol 9: 5-14, 2002.
22. Katano Y, Ishihata A, Morinobu S, and Endoh M. Modulation by aging of the coronary vascular response to endothelin-1 in the rat isolated perfused heart. Naunyn Schmiedebergs Arch Pharmacol 348: 82-87, 1993.
23. Kates AM, Herrero P, Dence C, Soto P, Srinivasan M, Delano DG, Ehsani A, and Gropler RJ. Impact of aging on substrate metabolism by the human heart. J Am Coll Cardiol 41: 293-299, 2003.
24. Klein CE, Nies A, and Gerber J. The effect of age on the beta-adrenergic lipolytic response in healthy humans. Clin Pharmacol Ther 56: 210-216, 1994.
25. Lakatta EG. Cardiovascular aging in health. Clin Geriatr Med 16: 419-444, 2000.
26. Lakatta EG. Cardiovascular aging research: the next horizons. J Am Geriatr Soc 47: 613-625, 1999,
27. Lipworth BJ. Clinical pharmacology of beta 3-adrenoceptors. Br J Clin Pharmacol 42: 291-300, 1996.
28. Morgan CR and Lavora A. Immunoassay of insulin; two antibody system. Diabetes 12: 115-120, 1963.
29. Poldermans D, Boersma E, Fioretti PM, van Urk H, Boomsma F, and Man in 't Veld AJ. Cardiac chronotropic responsiveness to beta-adrenoceptor stimulation is not reduced in the elderly. J Am Coll Cardiol 25: 995-999, 1995.
30. Ranallo RF and Rhodes EC. Lipid metabolism during exercise. Sports Med 26: 29-42, 1998.
31. Saddik M and Lopaschuk GD. Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. J Biol Chem 266: 8162-8170, 1991.
32. Senneff MJ, Geltman EM, and Bergmann SR. Noninvasive delineation of the effects of moderate aging on myocardial perfusion. J Nucl Med 32: 2037-2042, 1991.
33. Simonsen S and Kjekshus JK. The effect of free fatty acids on myocardial oxygen consumption during atrial pacing and catecholamine infusion in man. Circulation 58: 484-491, 1978,
34. Wei J. Advanced aging and the cardiovascular system. In: Cardiovascular Disease in the Octogenarian and Beyond, edited by Wenger N. London: Martin Dunitz, 1999, p. 9-18.
35. Woods SC and Porte D Jr. Neural control of the endocrine pancreas. Physiol Rev 54: 596-619, 1974.
36. 2-adrenergic responses without changes in inhibitory G proteins or receptor kinases. J Clin Invest 101: 1273-1282, 1998.